JP Morgan Chase’s LifeMD LFMD Stock Holding History

JP Morgan Chase’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Sell	56,127 -4,697	-8%	-$16.3K	﹤0.01%	5466
2025 Q4	$207K	Sell	60,824 -117	-0.2%	-$568	﹤0.01%	5525
2025 Q3	$414K	Sell	60,941 -351,630	-85%	-$2.9M	﹤0.01%	5140
2025 Q2	$5.62M	Buy	412,571 +352,004	+581%	+$3.32M	﹤0.01%	3043
2025 Q1	$329K	Buy	60,567 +5,363	+10%	+$30.4K	﹤0.01%	5020
2024 Q4	$273K	Sell	55,204 -32,969	-37%	-$173K	﹤0.01%	5339
2024 Q3	$462K	Buy	88,173 +73,389	+496%	+$423K	﹤0.01%	4949
2024 Q2	$101K	Buy	+14,784	New	+$135K	﹤0.01%	5509
2023 Q2	–	Sell	-88,792	Closed	-$151K	–	7154
2023 Q1	$151K	Buy	+88,792	New	+$157K	﹤0.01%	5226

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase's LFMD Position: Q1 2026 in Review

JP Morgan Chase reduced its LifeMD (LFMD) stake by 7.7% in Q1 2026, selling an estimated $16.3K and leaving 56,127 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #5466.

JP Morgan Chase first reported a position in LFMD in Q1 2023 and has held it in 9 quarters since. The position peaked at $5.62M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

JP Morgan Chase held 56,127 shares of LifeMD worth $202K as of Q1 2026.
JP Morgan Chase sold 4,697 LifeMD shares in Q1 2026, an estimated $16.3K.
LifeMD made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5466 holding.
JP Morgan Chase first reported a position in LifeMD in Q1 2023 and has held it in 9 quarters since.
JP Morgan Chase's LifeMD position peaked at $5.62M in Q2 2025.
102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.